Orphan diseases

Treatment failure of nontuberculosis pulmonary disease after adjunctive surgical resection
Noeul Kang, Byung Woo Jhun

European Respiratory Journal Sep 2021, 58 (suppl 65) OA1602; DOI: 10.1183/13993003.congress-2021.OA1602
The long-term outcome of adult pulmonary Langerhans cell histiocytosis: a national registry-based prospective cohort study
Amira Benattia, Emmanuelle Bugnet, Anouk Walter-Petrich, Gwenaël Lorillon, Sylvie Chevret, Abdellatif Tazi

European Respiratory Journal Sep 2020, 56 (suppl 64) 5252; DOI: 10.1183/13993003.congress-2020.5252
Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial
Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon L. F. Walsh, Martin Kolb, Dirk Koschel, Teng Moua, Susanne Stowasser, Rainer-Georg Goeldner, Rozsa Schlenker-Herceg, Kevin K. Brown

European Respiratory Journal Sep 2020, 56 (suppl 64) 4578; DOI: 10.1183/13993003.congress-2020.4578
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: a multicentric retrospective cohort study
Quentin Philippot, Caroline Kannengiesser, Ibrahima Ba, Anne Gondouin, Jean-Marc Naccache, Martine Reynaud-Gobert, Yurdagul Uzunhan, Benjamin Bondue, Dominique Israel Biet, Effrosyne Manali, Spyros Papiris, Lidwine Wemeau, Sandrine Hirschi, Hervé Mal, Hilario Nunes, Frédéric Schlemmer, Matthieu Rigaud, Vincent Cottin, Bruno Crestani, Raphaël Borie

European Respiratory Journal Sep 2020, 56 (suppl 64) 5254; DOI: 10.1183/13993003.congress-2020.5254
Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial
Claudia Valenzuela, Toby M Maher, Francesco Bonella, Alberto Pesci, Stephane Jouneau, Nina M Patel, Evans R Fernández Pérez, Rainer-Georg Goeldner, Susanne Stowasser, Rozsa Schlenker-Herceg, Manuel Quaresma, Vincent Cottin

European Respiratory Journal Sep 2020, 56 (suppl 64) 4577; DOI: 10.1183/13993003.congress-2020.4577
Management-related costs of Idiopathic Pulmonary Fibrosis (IPF) in Belgium
Danielle Strens, Benjamin Bondue, Caroline Dahlqvist, Hans Slabbynk, Julien Guiot, Guy F. Joos, Natacha Gusbin, Wim Janssens, Antoine Froidure, Wim Wuyts

European Respiratory Journal Sep 2020, 56 (suppl 64) 4810; DOI: 10.1183/13993003.congress-2020.4810
Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases
Diego Castillo Villegas, Silvia Barril Farre, Paloma Millan Billi, Oriol Sibila Vidal, Alfonso Luque, Paloma Acebo, Sonsoles Hortelano Blanco

European Respiratory Journal Sep 2020, 56 (suppl 64) 5253; DOI: 10.1183/13993003.congress-2020.5253
Does nintedanib have the same effect on FVC decline in patients with progressive fibrosing ILDs treated with DMARDs or glucocorticoids?
Nazia Chaudhuri, Vincent Cottin, Stefania Cerri, Michael Kreuter, Maria Otaola, Diego Castillo Villegas, Craig Glazer, Heiko Müller, Carl Coeck, Manuel Quaresma, Toby M Maher

European Respiratory Journal Sep 2020, 56 (suppl 64) 4576; DOI: 10.1183/13993003.congress-2020.4576
Identification and characterisation of twenty-two novel SERPINA1 pathological mutations
Stefania Ottaviani, Anna Maria Fra, Alice Maria Balderacchi, Valentina Barzon, Tomas Patrick Carroll, Davide Piloni, Francesca Mariani, Noel Gerard Mc Elvaney, Angelo Guido Corsico, Ilaria Ferrarotti

European Respiratory Journal Sep 2020, 56 (suppl 64) 4922; DOI: 10.1183/13993003.congress-2020.4922
Fibrosing cases of chronic eosinophilic pneumonia
Naoko Takeuchi, Toru Arai, Kazunobu Tachibana, Takayuki Takimoto, Yoshinobu Matsuda, Yu Kurahara, Kanako Katayama, Yukihiro Nakamura, Reiko Sugawara, Chikatoshi Sugimoto, Seiji Hayashi, Masanori Akira, Takahiko Kasai, Yoshikazu Inoue

European Respiratory Journal Sep 2020, 56 (suppl 64) 3480; DOI: 10.1183/13993003.congress-2020.3480

Main menu

User menu

Search

Orphan diseases

Pages

Contact us